Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dacinostat

Known as: NVP-LAQ 824 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking
Histone deacetylases (HDACs) are a family of proteins whose main function is the removal of acetyl groups from lysine residues… Expand
2019
2019
A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma
BackgroundMedulloblastoma is the most frequently occurring malignant brain tumor in children. Current treatment strategies for… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2019
2019
Comparison of Different Histone Deacetylase Inhibitors in Attenuating Inflammatory Pain in Rats
Histone deacetylase inhibitors (HDACIs), which interfere with the epigenetic process of histone acetylation, have shown analgesic… Expand
  • figure 2
  • figure 1
  • figure 2
  • figure 3
  • figure 3
2017
2017
Quantitative measurement of intracellular HDAC1/2 drug occupancy using a trans-cyclooctene largazole thiol probe.
Histone deacetylases (HDACs) regulate diverse cellular processes, and are promising targets for a number of diseases. Here we… Expand
2016
2016
A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
Deregulated epigenetic activity of Histone deacetylase 1 (HDAC1) in tumor development and carcinogenesis pronounces it as… Expand
2016
2016
Transcript, methylation and molecular docking analyses of the effects of HDAC inhibitors, SAHA and Dacinostat, on SMN2 expression in fibroblasts of SMA patients
Several histone deacetylase inhibitors (HDACis) are known to increase Survival Motor Neuron 2 (SMN2) expression for the therapy… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
2015
2015
Strategy for enhancing the therapeutic efficacy of histone deacetylase inhibitor dacinostat: the novel paradigm to tackle monotonous cancer chemoresistance
  • S. A. Ganai
  • Archives of pharmacal research
  • 2015
    • Corpus ID: 25605184
Histone deacetylases (HDACs) regulate gene expression by creating the closed state of chromatin via histone hypoacetylation… Expand
Review
2012
Review
2012
Improving student's modeling framework in a tutorial-like system based on Pursuit learning automata and reinforcement learning
Intelligent Tutorial Systems are educational software packages that occupy Artificial Intelligence (AI) techniques and methods to… Expand
  • figure 1
  • figure 2
  • table I
  • table III
  • table V
2011
2011
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors.
Histone deacetylase (HDAC) inhibitors have shown promise in treating various forms of cancer. However, many HDAC inhibitors from… Expand
2010
2010
Conformational refinement of hydroxamate-based histone deacetylase inhibitors and exploration of 3-piperidin-3-ylindole analogues of dacinostat (LAQ824).
Inspired by natural product HDAC inhibitors, we prepared a series of conformationally restrained HDAC inhibitors based on the… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE